Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
07/2003
07/15/2003US6592870 Method and kit using recombinant proteins in fusion of porcine reproductive and respiratory syndrome virus and for diagnosis
07/15/2003US6592868 Produced by hybridoma having ATCC Accession Number HB 10916
07/10/2003WO2003056332A1 Diagnostic for scleroderma
07/10/2003WO2003055994A1 Hxhv virus, nucleic material, peptide material and uses
07/10/2003WO2003055993A1 Composition of antibody specifically binding to cd20
07/10/2003WO2003055980A2 Il-17 like molecules and uses thereof
07/10/2003WO2003055979A2 ANTIBODIES THAT IMMUNOSPECIFICALLY BIND TO BLyS
07/10/2003WO2003055917A2 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours
07/10/2003WO2003055913A2 Secreted protein
07/10/2003WO2003055912A2 Secreted proteins
07/10/2003WO2003055911A2 Cystine-knot fold protein
07/10/2003WO2003055910A1 Beta-amyloid binding factors and inhibitors thereof
07/10/2003WO2003055908A2 Bag3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases
07/10/2003WO2003055529A1 Dna vaccine for periodontal disease
07/10/2003WO2003055519A1 Medicinal agent and method for curing diseases accompanied with vascular dystonia
07/10/2003WO2003055518A1 Method for curing immunopathosis and medicinal agent for carrying out said method
07/10/2003WO2003055517A1 Method for correcting immune response and medicinal agent
07/10/2003WO2003055516A1 Pecam-1 modulation
07/10/2003WO2003055515A1 Individualized anti-cancer antibodies
07/10/2003WO2003055502A1 Immunoglobulin composition
07/10/2003WO2003055440A2 Compositions and methods for the treatement of immune related diseases
07/10/2003WO2003033677A3 Dimerized growth factor and materials and methods for producing it
07/10/2003WO2003008452A3 Bispecific monoclonal antibodies to il-12 and il-18 receptors
07/10/2003WO2003002765A3 Methods for the diagnosis of cancer based on the obcam and ntm genes
07/10/2003WO2002096937A3 Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
07/10/2003WO2002090520A3 Toll/interleukin-1 receptor adaptor protein (tirap)
07/10/2003WO2002088306A3 Humanized antibodies
07/10/2003WO2002072788A3 Chronic obstructive pulmonary disease-related immunglobulin derived proteins, compositions, methods and uses
07/10/2003WO2002063008A3 Intracellular signaling molecules
07/10/2003WO2002059326A3 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof
07/10/2003WO2002059267A3 Constitutively desensitized g protein-coupled receptors
07/10/2003WO2002046409A3 Proteins and nucleic acids encoding same
07/10/2003WO2002046238A3 Rationally designed antibodies
07/10/2003WO2002043570A3 METHODS FOR THE PREVENTION AND TREATMENT OF CANCER USING ANTI-C3B(i) ANTIBODIES
07/10/2003WO2002040541A3 Transporters and ion channels
07/10/2003WO2002028408A9 Compositions and methods for the transport of biologically active agents across cellular barriers
07/10/2003WO2002018581A3 G-protein coupled receptors
07/10/2003WO2002013845A3 Inflammation related g-protein coupled receptor
07/10/2003WO2002010335A3 ANTIBODIES SPECIFIC FOR UNGULATE PrP
07/10/2003WO2001096523A3 Polynucleotides related to colon cancer
07/10/2003US20030130496 Immunoglobulins; cloning, amplifying and encoding by DNA sequences, polymerase chain reaction
07/10/2003US20030130494 Mammalian chemokine reagents
07/10/2003US20030130491 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030130490 Genetic engineered protein drugs, such as thrombolytic agents, interferons, interleukins, erythropoietins; extracellular
07/10/2003US20030130489 Genetic engineered protein drugs, such as thrombolytic agents, interferons, interleukins, erythropoietins
07/10/2003US20030130483 Amino acid sequences free of signal peptide, encoded by cDNA; fusion proteins
07/10/2003US20030130324 Method for preventing or controlling cataract
07/10/2003US20030130214 Proteins, compositions, diagnostic and therapeutic uses thereof
07/10/2003US20030130187 Porcine adenovirus type 3 genome
07/10/2003US20030130182 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030130181 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030130166 Polynucleotide encoding a human junctional adhesion protein (JAM2)
07/10/2003US20030129752 MEKK/JNKK-contingent (mitogen extracellular signal regulated kinases (MEKK), Jun N-terminal kinase) signal transduction pathway; tumor necrosis factor; interleukins
07/10/2003US20030129746 Monoclonal antibodies for Hepatitis C virus (HCV) infection
07/10/2003US20030129706 Fhm, a novel member of the TNF ligand supergene family
07/10/2003US20030129702 DNA encoding galanin GALR2 receptors and uses thereof
07/10/2003US20030129698 Involved in homo and heterotrimerization or oligomerization
07/10/2003US20030129697 Endothelial and Smooth muscle cell-Derived Neuropilin-like molecule; effective in restenosis after percutaneous transluminal coronany angioplasty and arterial sclerosis
07/10/2003US20030129696 Polynucleotides and polypeptides encoding receptors
07/10/2003US20030129695 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030129694 Linking a bioactive molecule to a cell expressing certain PRO polypeptides by contacting the cell with a specific PRO polypeptide bound to the molecule
07/10/2003US20030129693 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030129692 Linking a bioactive molecule to a cell expressing certain PRO polypeptides by contacting the cell with a specific PRO polypeptide bound to the molecule
07/10/2003US20030129690 Linking a bioactive molecule to a cell expressing certain PRO polypeptides by contacting the cell with a specific PRO polypeptide bound to the molecule
07/10/2003US20030129689 Nucleotide sequence that encodes a PRO polypeptide.
07/10/2003US20030129686 Novel nucleic acid and polypeptide molecules
07/10/2003US20030129674 Diagnostic method for screening complement regulatory protein levels to predict spontaneous abortion
07/10/2003US20030129661 Antibody raised against total extractable denatured components of meals from different animal and plant species and its use to detect and quantify materials derived from these species in animal fodder
07/10/2003US20030129658 Novel protease
07/10/2003US20030129652 Human sperm specific lysozyme-like proteins
07/10/2003US20030129650 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030129645 Can be used as models for the development of human therapeutic targets, aid in the identification of therapeutic proteins, and serve as targets for the development of human therapeutic agents that modulate kinase activity
07/10/2003US20030129644 Used in gene therapy
07/10/2003US20030129643 T1 receptor-like ligand I
07/10/2003US20030129638 Reagents for antagonizing the protein-protein interaction between Raf-1 and apoptosis signal-regulating kinase and uses therefor
07/10/2003US20030129628 Anti-idiotypic antibody and its use in diagnosis and therapy in HIV-related disease
07/10/2003US20030129613 SECX polynucleotides and the membrane-associated or secreted polypeptides encoded by them
07/10/2003US20030129606 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
07/10/2003US20030129592 Identification and characterization of extracellular polypeptides having homology to EGF
07/10/2003US20030129587 Antigen/antibody specificity exchanger
07/10/2003US20030129582 Method for determining early HCV seroconversion
07/10/2003US20030129202 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof
07/10/2003US20030129193 Comprises antibody-coagulant constructs (coaguligands) for induction of (drug resistant) tumor thrombosis/necrosis
07/10/2003US20030129190 FX activity in cells in cancer, inflammatory responses and diseases and in autoimmunity
07/10/2003US20030129189 Angiogenesis inhibitors for treament of inflammation, cachexia, septic shock, cerebral malaria, arthritis, and graft-rejection
07/10/2003US20030129187 Complement pathway inhibitors binding to C5 and C5a without preventing formation of C5b
07/10/2003US20030129186 Compositions and methods for modulating blood-brain barrier transport
07/10/2003US20030129185 Chimeric antibodies; lymphocytes; genetic engineering; for treatment of myeloma
07/10/2003US20030129184 Monoclonal antibody specific to polypeptide which induces interferon-gamma production
07/10/2003US20030129159 Derivatisation of proteins
07/10/2003US20030129132 IL-13 receptor specific chimeric proteins & uses thereof
07/10/2003CA2471924A1 Bag3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases, and for modulation of cell survival and/or death
07/10/2003CA2471647A1 Antibody composition which specifically binds to cd20
07/10/2003CA2471306A1 Secreted proteins
07/10/2003CA2471206A1 Individualized anti-cancer antibodies
07/10/2003CA2471130A1 Il-17 like molecules and uses thereof
07/10/2003CA2470781A1 Cystine-knot fold protein
07/10/2003CA2470696A1 Pecam-1 modulation
07/10/2003CA2470666A1 Secreted protein
07/10/2003CA2469690A1 Beta-amyloid binding factors and inhibitors thereof
1 ... 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 ... 1494